Tech Company Financing Transactions
Oncobiologics Funding Round
On 9/27/2017, Oncobiologics announced $3.3 million in investment from private investors.
Transaction Overview
Company Name
Announced On
9/27/2017
Transaction Type
Venture Equity
Amount
$3,262,800
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7 Clarke Dr.
Cranbury, NJ 08512
USA
Cranbury, NJ 08512
USA
Phone
Website
Email Address
Overview
Oncobiologics is committed to advancing biotherapeutics to treat serious diseases, including cancer and immune disorders through the development of both novel molecules using the TRIDENT� platform and biosimilar monocolonal antibodies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lawrence Kenyon
Chief Medical Officer
Kenneth Bahrt
VP - Bus. Development
Stephen McAndrew
VP - Manufacturing
Chuck Hart
VP - Regulatory Affairs
Myrna Thomas
Browse more venture capital transactions:
Prev: 9/27/2017: Tempus venture capital transaction
Next: 9/27/2017: Tia venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs